カテゴリー： 世界, 部品/材料, QYResearch

医療用放射性同位体の世界市場インサイト・予測（～2028年）

【英語タイトル】Global Medical Radioactive Isotopes Market Insights, Forecast to 2028

QYResearchが出版した調査資料（QY22JLX01556）・商品コード：QY22JLX01556
・発行会社（調査会社）：QYResearch
・発行日：2022年7月（※2025年版があります。お問い合わせください。）
・ページ数：90
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：化学＆材料
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥735,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,102,500見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,470,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

COVID-19のパンデミックにより、医療用放射性同位体のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に医療用放射性同位体の世界市場のxxx％を占める「Tc-99m」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「核治療」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
医療用放射性同位体の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの医療用放射性同位体市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

医療用放射性同位体のグローバル主要企業には、NRG、IRE、ANSTO、NTP Radioisotopes、China National Nuclear Corporation、Rosatom、Nordion、Eckert & Ziegler Strahlen、Polatomなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

医療用放射性同位体市場は、種類と用途によって区分されます。世界の医療用放射性同位体市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
Tc-99m、コバルト60、ヨウ素放射性同位元素

【用途別セグメント】
核治療、機器放射線源、診断、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 医療用放射性同位体製品概要
- 種類別市場（Tc-99m、コバルト60、ヨウ素放射性同位元素）
- 用途別市場（核治療、機器放射線源、診断、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界の医療用放射性同位体販売量予測2017-2028
- 世界の医療用放射性同位体売上予測2017-2028
- 医療用放射性同位体の地域別販売量
- 医療用放射性同位体の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別医療用放射性同位体販売量
- 主要メーカー別医療用放射性同位体売上
- 主要メーカー別医療用放射性同位体価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（Tc-99m、コバルト60、ヨウ素放射性同位元素）
- 医療用放射性同位体の種類別販売量
- 医療用放射性同位体の種類別売上
- 医療用放射性同位体の種類別価格
・用途別市場規模（核治療、機器放射線源、診断、その他）
- 医療用放射性同位体の用途別販売量
- 医療用放射性同位体の用途別売上
- 医療用放射性同位体の用途別価格
・北米市場
- 北米の医療用放射性同位体市場規模（種類別、用途別）
- 主要国別の医療用放射性同位体市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの医療用放射性同位体市場規模（種類別、用途別）
- 主要国別の医療用放射性同位体市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の医療用放射性同位体市場規模（種類別、用途別）
- 主要国別の医療用放射性同位体市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の医療用放射性同位体市場規模（種類別、用途別）
- 主要国別の医療用放射性同位体市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの医療用放射性同位体市場規模（種類別、用途別）
- 主要国別の医療用放射性同位体市場規模（トルコ、サウジアラビア）
・企業情報
NRG、IRE、ANSTO、NTP Radioisotopes、China National Nuclear Corporation、Rosatom、Nordion、Eckert & Ziegler Strahlen、Polatom
・産業チェーン及び販売チャネル分析
- 医療用放射性同位体の産業チェーン分析
- 医療用放射性同位体の原材料
- 医療用放射性同位体の生産プロセス
- 医療用放射性同位体の販売及びマーケティング
- 医療用放射性同位体の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 医療用放射性同位体の産業動向
- 医療用放射性同位体のマーケットドライバー
- 医療用放射性同位体の課題
- 医療用放射性同位体の阻害要因
・主な調査結果

Market Analysis and Insights: Global Medical Radioactive Isotopes Market
Due to the COVID-19 pandemic, the global Medical Radioactive Isotopes market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Tc-99m accounting for % of the Medical Radioactive Isotopes global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Nuclear Therapy segment is altered to an % CAGR throughout this forecast period.
China Medical Radioactive Isotopes market size is valued at US$ million in 2021, while the US and Europe Medical Radioactive Isotopes are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Medical Radioactive Isotopes landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Medical Radioactive Isotopes include NRG, IRE, ANSTO, NTP Radioisotopes, China National Nuclear Corporation, Rosatom, Nordion, Eckert & Ziegler Strahlen and Polatom. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Medical Radioactive Isotopes capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Medical Radioactive Isotopes by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Medical Radioactive Isotopes Scope and Segment
Medical Radioactive Isotopes market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Medical Radioactive Isotopes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Tc-99m
Cobalt-60
Iodine Radioisotopes
Segment by Application
Nuclear Therapy
Equipment Radioactive Source
Diagnosis
Others
By Company
NRG
IRE
ANSTO
NTP Radioisotopes
China National Nuclear Corporation
Rosatom
Nordion
Eckert & Ziegler Strahlen
Polatom
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Medical Radioactive Isotopes Product Introduction
1.2 Market by Type
1.2.1 Global Medical Radioactive Isotopes Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Tc-99m
1.2.3 Cobalt-60
1.2.4 Iodine Radioisotopes
1.3 Market by Application
1.3.1 Global Medical Radioactive Isotopes Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Nuclear Therapy
1.3.3 Equipment Radioactive Source
1.3.4 Diagnosis
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Medical Radioactive Isotopes Production
2.1 Global Medical Radioactive Isotopes Production Capacity (2017-2028)
2.2 Global Medical Radioactive Isotopes Production by Region: 2017 VS 2021 VS 2028
2.3 Global Medical Radioactive Isotopes Production by Region
2.3.1 Global Medical Radioactive Isotopes Historic Production by Region (2017-2022)
2.3.2 Global Medical Radioactive Isotopes Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Medical Radioactive Isotopes Sales in Volume & Value Estimates and Forecasts
3.1 Global Medical Radioactive Isotopes Sales Estimates and Forecasts 2017-2028
3.2 Global Medical Radioactive Isotopes Revenue Estimates and Forecasts 2017-2028
3.3 Global Medical Radioactive Isotopes Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Medical Radioactive Isotopes Sales by Region
3.4.1 Global Medical Radioactive Isotopes Sales by Region (2017-2022)
3.4.2 Global Sales Medical Radioactive Isotopes by Region (2023-2028)
3.5 Global Medical Radioactive Isotopes Revenue by Region
3.5.1 Global Medical Radioactive Isotopes Revenue by Region (2017-2022)
3.5.2 Global Medical Radioactive Isotopes Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Medical Radioactive Isotopes Production Capacity by Manufacturers
4.2 Global Medical Radioactive Isotopes Sales by Manufacturers
4.2.1 Global Medical Radioactive Isotopes Sales by Manufacturers (2017-2022)
4.2.2 Global Medical Radioactive Isotopes Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Medical Radioactive Isotopes in 2021
4.3 Global Medical Radioactive Isotopes Revenue by Manufacturers
4.3.1 Global Medical Radioactive Isotopes Revenue by Manufacturers (2017-2022)
4.3.2 Global Medical Radioactive Isotopes Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Medical Radioactive Isotopes Revenue in 2021
4.4 Global Medical Radioactive Isotopes Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Medical Radioactive Isotopes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Medical Radioactive Isotopes Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Medical Radioactive Isotopes Sales by Type
5.1.1 Global Medical Radioactive Isotopes Historical Sales by Type (2017-2022)
5.1.2 Global Medical Radioactive Isotopes Forecasted Sales by Type (2023-2028)
5.1.3 Global Medical Radioactive Isotopes Sales Market Share by Type (2017-2028)
5.2 Global Medical Radioactive Isotopes Revenue by Type
5.2.1 Global Medical Radioactive Isotopes Historical Revenue by Type (2017-2022)
5.2.2 Global Medical Radioactive Isotopes Forecasted Revenue by Type (2023-2028)
5.2.3 Global Medical Radioactive Isotopes Revenue Market Share by Type (2017-2028)
5.3 Global Medical Radioactive Isotopes Price by Type
5.3.1 Global Medical Radioactive Isotopes Price by Type (2017-2022)
5.3.2 Global Medical Radioactive Isotopes Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Medical Radioactive Isotopes Sales by Application
6.1.1 Global Medical Radioactive Isotopes Historical Sales by Application (2017-2022)
6.1.2 Global Medical Radioactive Isotopes Forecasted Sales by Application (2023-2028)
6.1.3 Global Medical Radioactive Isotopes Sales Market Share by Application (2017-2028)
6.2 Global Medical Radioactive Isotopes Revenue by Application
6.2.1 Global Medical Radioactive Isotopes Historical Revenue by Application (2017-2022)
6.2.2 Global Medical Radioactive Isotopes Forecasted Revenue by Application (2023-2028)
6.2.3 Global Medical Radioactive Isotopes Revenue Market Share by Application (2017-2028)
6.3 Global Medical Radioactive Isotopes Price by Application
6.3.1 Global Medical Radioactive Isotopes Price by Application (2017-2022)
6.3.2 Global Medical Radioactive Isotopes Price Forecast by Application (2023-2028)
7 North America
7.1 North America Medical Radioactive Isotopes Market Size by Type
7.1.1 North America Medical Radioactive Isotopes Sales by Type (2017-2028)
7.1.2 North America Medical Radioactive Isotopes Revenue by Type (2017-2028)
7.2 North America Medical Radioactive Isotopes Market Size by Application
7.2.1 North America Medical Radioactive Isotopes Sales by Application (2017-2028)
7.2.2 North America Medical Radioactive Isotopes Revenue by Application (2017-2028)
7.3 North America Medical Radioactive Isotopes Sales by Country
7.3.1 North America Medical Radioactive Isotopes Sales by Country (2017-2028)
7.3.2 North America Medical Radioactive Isotopes Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Medical Radioactive Isotopes Market Size by Type
8.1.1 Europe Medical Radioactive Isotopes Sales by Type (2017-2028)
8.1.2 Europe Medical Radioactive Isotopes Revenue by Type (2017-2028)
8.2 Europe Medical Radioactive Isotopes Market Size by Application
8.2.1 Europe Medical Radioactive Isotopes Sales by Application (2017-2028)
8.2.2 Europe Medical Radioactive Isotopes Revenue by Application (2017-2028)
8.3 Europe Medical Radioactive Isotopes Sales by Country
8.3.1 Europe Medical Radioactive Isotopes Sales by Country (2017-2028)
8.3.2 Europe Medical Radioactive Isotopes Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Medical Radioactive Isotopes Market Size by Type
9.1.1 Asia Pacific Medical Radioactive Isotopes Sales by Type (2017-2028)
9.1.2 Asia Pacific Medical Radioactive Isotopes Revenue by Type (2017-2028)
9.2 Asia Pacific Medical Radioactive Isotopes Market Size by Application
9.2.1 Asia Pacific Medical Radioactive Isotopes Sales by Application (2017-2028)
9.2.2 Asia Pacific Medical Radioactive Isotopes Revenue by Application (2017-2028)
9.3 Asia Pacific Medical Radioactive Isotopes Sales by Region
9.3.1 Asia Pacific Medical Radioactive Isotopes Sales by Region (2017-2028)
9.3.2 Asia Pacific Medical Radioactive Isotopes Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Medical Radioactive Isotopes Market Size by Type
10.1.1 Latin America Medical Radioactive Isotopes Sales by Type (2017-2028)
10.1.2 Latin America Medical Radioactive Isotopes Revenue by Type (2017-2028)
10.2 Latin America Medical Radioactive Isotopes Market Size by Application
10.2.1 Latin America Medical Radioactive Isotopes Sales by Application (2017-2028)
10.2.2 Latin America Medical Radioactive Isotopes Revenue by Application (2017-2028)
10.3 Latin America Medical Radioactive Isotopes Sales by Country
10.3.1 Latin America Medical Radioactive Isotopes Sales by Country (2017-2028)
10.3.2 Latin America Medical Radioactive Isotopes Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Medical Radioactive Isotopes Market Size by Type
11.1.1 Middle East and Africa Medical Radioactive Isotopes Sales by Type (2017-2028)
11.1.2 Middle East and Africa Medical Radioactive Isotopes Revenue by Type (2017-2028)
11.2 Middle East and Africa Medical Radioactive Isotopes Market Size by Application
11.2.1 Middle East and Africa Medical Radioactive Isotopes Sales by Application (2017-2028)
11.2.2 Middle East and Africa Medical Radioactive Isotopes Revenue by Application (2017-2028)
11.3 Middle East and Africa Medical Radioactive Isotopes Sales by Country
11.3.1 Middle East and Africa Medical Radioactive Isotopes Sales by Country (2017-2028)
11.3.2 Middle East and Africa Medical Radioactive Isotopes Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 NRG
12.1.1 NRG Corporation Information
12.1.2 NRG Overview
12.1.3 NRG Medical Radioactive Isotopes Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 NRG Medical Radioactive Isotopes Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 NRG Recent Developments
12.2 IRE
12.2.1 IRE Corporation Information
12.2.2 IRE Overview
12.2.3 IRE Medical Radioactive Isotopes Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 IRE Medical Radioactive Isotopes Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 IRE Recent Developments
12.3 ANSTO
12.3.1 ANSTO Corporation Information
12.3.2 ANSTO Overview
12.3.3 ANSTO Medical Radioactive Isotopes Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 ANSTO Medical Radioactive Isotopes Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 ANSTO Recent Developments
12.4 NTP Radioisotopes
12.4.1 NTP Radioisotopes Corporation Information
12.4.2 NTP Radioisotopes Overview
12.4.3 NTP Radioisotopes Medical Radioactive Isotopes Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 NTP Radioisotopes Medical Radioactive Isotopes Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 NTP Radioisotopes Recent Developments
12.5 China National Nuclear Corporation
12.5.1 China National Nuclear Corporation Corporation Information
12.5.2 China National Nuclear Corporation Overview
12.5.3 China National Nuclear Corporation Medical Radioactive Isotopes Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 China National Nuclear Corporation Medical Radioactive Isotopes Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 China National Nuclear Corporation Recent Developments
12.6 Rosatom
12.6.1 Rosatom Corporation Information
12.6.2 Rosatom Overview
12.6.3 Rosatom Medical Radioactive Isotopes Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Rosatom Medical Radioactive Isotopes Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Rosatom Recent Developments
12.7 Nordion
12.7.1 Nordion Corporation Information
12.7.2 Nordion Overview
12.7.3 Nordion Medical Radioactive Isotopes Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Nordion Medical Radioactive Isotopes Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Nordion Recent Developments
12.8 Eckert & Ziegler Strahlen
12.8.1 Eckert & Ziegler Strahlen Corporation Information
12.8.2 Eckert & Ziegler Strahlen Overview
12.8.3 Eckert & Ziegler Strahlen Medical Radioactive Isotopes Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Eckert & Ziegler Strahlen Medical Radioactive Isotopes Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Eckert & Ziegler Strahlen Recent Developments
12.9 Polatom
12.9.1 Polatom Corporation Information
12.9.2 Polatom Overview
12.9.3 Polatom Medical Radioactive Isotopes Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Polatom Medical Radioactive Isotopes Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Polatom Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Medical Radioactive Isotopes Industry Chain Analysis
13.2 Medical Radioactive Isotopes Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Medical Radioactive Isotopes Production Mode & Process
13.4 Medical Radioactive Isotopes Sales and Marketing
13.4.1 Medical Radioactive Isotopes Sales Channels
13.4.2 Medical Radioactive Isotopes Distributors
13.5 Medical Radioactive Isotopes Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Medical Radioactive Isotopes Industry Trends
14.2 Medical Radioactive Isotopes Market Drivers
14.3 Medical Radioactive Isotopes Market Challenges
14.4 Medical Radioactive Isotopes Market Restraints
15 Key Finding in The Global Medical Radioactive Isotopes Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Medical Radioactive Isotopes Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Tc-99m
Table 3. Major Manufacturers of Cobalt-60
Table 4. Major Manufacturers of Iodine Radioisotopes
Table 5. Global Medical Radioactive Isotopes Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 6. Global Medical Radioactive Isotopes Production by Region: 2017 VS 2021 VS 2028 (Curie)
Table 7. Global Medical Radioactive Isotopes Production by Region (2017-2022) & (Curie)
Table 8. Global Medical Radioactive Isotopes Production Market Share by Region (2017-2022)
Table 9. Global Medical Radioactive Isotopes Production by Region (2023-2028) & (Curie)
Table 10. Global Medical Radioactive Isotopes Production Market Share by Region (2023-2028)
Table 11. Global Medical Radioactive Isotopes Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 12. Global Medical Radioactive Isotopes Sales by Region (2017-2022) & (Curie)
Table 13. Global Medical Radioactive Isotopes Sales Market Share by Region (2017-2022)
Table 14. Global Medical Radioactive Isotopes Sales by Region (2023-2028) & (Curie)
Table 15. Global Medical Radioactive Isotopes Sales Market Share by Region (2023-2028)
Table 16. Global Medical Radioactive Isotopes Revenue by Region (2017-2022) & (US$ Million)
Table 17. Global Medical Radioactive Isotopes Revenue Market Share by Region (2017-2022)
Table 18. Global Medical Radioactive Isotopes Revenue by Region (2023-2028) & (US$ Million)
Table 19. Global Medical Radioactive Isotopes Revenue Market Share by Region (2023-2028)
Table 20. Global Medical Radioactive Isotopes Production Capacity by Manufacturers (2017-2022) & (Curie)
Table 21. Global Medical Radioactive Isotopes Capacity Market Share by Manufacturers (2017-2022)
Table 22. Global Medical Radioactive Isotopes Sales by Manufacturers (2017-2022) & (Curie)
Table 23. Global Medical Radioactive Isotopes Sales Market Share by Manufacturers (2017-2022)
Table 24. Global Medical Radioactive Isotopes Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 25. Global Medical Radioactive Isotopes Revenue Share by Manufacturers (2017-2022)
Table 26. Medical Radioactive Isotopes Price by Manufacturers 2017-2022 (US$/Curie)
Table 27. Global Medical Radioactive Isotopes Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Medical Radioactive Isotopes by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Radioactive Isotopes as of 2021)
Table 29. Medical Radioactive Isotopes Manufacturing Base Distribution and Headquarters
Table 30. Manufacturers Medical Radioactive Isotopes Product Offered
Table 31. Date of Manufacturers Enter into Medical Radioactive Isotopes Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Medical Radioactive Isotopes Sales by Type (2017-2022) & (Curie)
Table 34. Global Medical Radioactive Isotopes Sales by Type (2023-2028) & (Curie)
Table 35. Global Medical Radioactive Isotopes Sales Share by Type (2017-2022)
Table 36. Global Medical Radioactive Isotopes Sales Share by Type (2023-2028)
Table 37. Global Medical Radioactive Isotopes Revenue by Type (2017-2022) & (US$ Million)
Table 38. Global Medical Radioactive Isotopes Revenue by Type (2023-2028) & (US$ Million)
Table 39. Global Medical Radioactive Isotopes Revenue Share by Type (2017-2022)
Table 40. Global Medical Radioactive Isotopes Revenue Share by Type (2023-2028)
Table 41. Medical Radioactive Isotopes Price by Type (2017-2022) & (US$/Curie)
Table 42. Global Medical Radioactive Isotopes Price Forecast by Type (2023-2028) & (US$/Curie)
Table 43. Global Medical Radioactive Isotopes Sales by Application (2017-2022) & (Curie)
Table 44. Global Medical Radioactive Isotopes Sales by Application (2023-2028) & (Curie)
Table 45. Global Medical Radioactive Isotopes Sales Share by Application (2017-2022)
Table 46. Global Medical Radioactive Isotopes Sales Share by Application (2023-2028)
Table 47. Global Medical Radioactive Isotopes Revenue by Application (2017-2022) & (US$ Million)
Table 48. Global Medical Radioactive Isotopes Revenue by Application (2023-2028) & (US$ Million)
Table 49. Global Medical Radioactive Isotopes Revenue Share by Application (2017-2022)
Table 50. Global Medical Radioactive Isotopes Revenue Share by Application (2023-2028)
Table 51. Medical Radioactive Isotopes Price by Application (2017-2022) & (US$/Curie)
Table 52. Global Medical Radioactive Isotopes Price Forecast by Application (2023-2028) & (US$/Curie)
Table 53. North America Medical Radioactive Isotopes Sales by Type (2017-2022) & (Curie)
Table 54. North America Medical Radioactive Isotopes Sales by Type (2023-2028) & (Curie)
Table 55. North America Medical Radioactive Isotopes Revenue by Type (2017-2022) & (US$ Million)
Table 56. North America Medical Radioactive Isotopes Revenue by Type (2023-2028) & (US$ Million)
Table 57. North America Medical Radioactive Isotopes Sales by Application (2017-2022) & (Curie)
Table 58. North America Medical Radioactive Isotopes Sales by Application (2023-2028) & (Curie)
Table 59. North America Medical Radioactive Isotopes Revenue by Application (2017-2022) & (US$ Million)
Table 60. North America Medical Radioactive Isotopes Revenue by Application (2023-2028) & (US$ Million)
Table 61. North America Medical Radioactive Isotopes Sales by Country (2017-2022) & (Curie)
Table 62. North America Medical Radioactive Isotopes Sales by Country (2023-2028) & (Curie)
Table 63. North America Medical Radioactive Isotopes Revenue by Country (2017-2022) & (US$ Million)
Table 64. North America Medical Radioactive Isotopes Revenue by Country (2023-2028) & (US$ Million)
Table 65. Europe Medical Radioactive Isotopes Sales by Type (2017-2022) & (Curie)
Table 66. Europe Medical Radioactive Isotopes Sales by Type (2023-2028) & (Curie)
Table 67. Europe Medical Radioactive Isotopes Revenue by Type (2017-2022) & (US$ Million)
Table 68. Europe Medical Radioactive Isotopes Revenue by Type (2023-2028) & (US$ Million)
Table 69. Europe Medical Radioactive Isotopes Sales by Application (2017-2022) & (Curie)
Table 70. Europe Medical Radioactive Isotopes Sales by Application (2023-2028) & (Curie)
Table 71. Europe Medical Radioactive Isotopes Revenue by Application (2017-2022) & (US$ Million)
Table 72. Europe Medical Radioactive Isotopes Revenue by Application (2023-2028) & (US$ Million)
Table 73. Europe Medical Radioactive Isotopes Sales by Country (2017-2022) & (Curie)
Table 74. Europe Medical Radioactive Isotopes Sales by Country (2023-2028) & (Curie)
Table 75. Europe Medical Radioactive Isotopes Revenue by Country (2017-2022) & (US$ Million)
Table 76. Europe Medical Radioactive Isotopes Revenue by Country (2023-2028) & (US$ Million)
Table 77. Asia Pacific Medical Radioactive Isotopes Sales by Type (2017-2022) & (Curie)
Table 78. Asia Pacific Medical Radioactive Isotopes Sales by Type (2023-2028) & (Curie)
Table 79. Asia Pacific Medical Radioactive Isotopes Revenue by Type (2017-2022) & (US$ Million)
Table 80. Asia Pacific Medical Radioactive Isotopes Revenue by Type (2023-2028) & (US$ Million)
Table 81. Asia Pacific Medical Radioactive Isotopes Sales by Application (2017-2022) & (Curie)
Table 82. Asia Pacific Medical Radioactive Isotopes Sales by Application (2023-2028) & (Curie)
Table 83. Asia Pacific Medical Radioactive Isotopes Revenue by Application (2017-2022) & (US$ Million)
Table 84. Asia Pacific Medical Radioactive Isotopes Revenue by Application (2023-2028) & (US$ Million)
Table 85. Asia Pacific Medical Radioactive Isotopes Sales by Region (2017-2022) & (Curie)
Table 86. Asia Pacific Medical Radioactive Isotopes Sales by Region (2023-2028) & (Curie)
Table 87. Asia Pacific Medical Radioactive Isotopes Revenue by Region (2017-2022) & (US$ Million)
Table 88. Asia Pacific Medical Radioactive Isotopes Revenue by Region (2023-2028) & (US$ Million)
Table 89. Latin America Medical Radioactive Isotopes Sales by Type (2017-2022) & (Curie)
Table 90. Latin America Medical Radioactive Isotopes Sales by Type (2023-2028) & (Curie)
Table 91. Latin America Medical Radioactive Isotopes Revenue by Type (2017-2022) & (US$ Million)
Table 92. Latin America Medical Radioactive Isotopes Revenue by Type (2023-2028) & (US$ Million)
Table 93. Latin America Medical Radioactive Isotopes Sales by Application (2017-2022) & (Curie)
Table 94. Latin America Medical Radioactive Isotopes Sales by Application (2023-2028) & (Curie)
Table 95. Latin America Medical Radioactive Isotopes Revenue by Application (2017-2022) & (US$ Million)
Table 96. Latin America Medical Radioactive Isotopes Revenue by Application (2023-2028) & (US$ Million)
Table 97. Latin America Medical Radioactive Isotopes Sales by Country (2017-2022) & (Curie)
Table 98. Latin America Medical Radioactive Isotopes Sales by Country (2023-2028) & (Curie)
Table 99. Latin America Medical Radioactive Isotopes Revenue by Country (2017-2022) & (US$ Million)
Table 100. Latin America Medical Radioactive Isotopes Revenue by Country (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Medical Radioactive Isotopes Sales by Type (2017-2022) & (Curie)
Table 102. Middle East and Africa Medical Radioactive Isotopes Sales by Type (2023-2028) & (Curie)
Table 103. Middle East and Africa Medical Radioactive Isotopes Revenue by Type (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Medical Radioactive Isotopes Revenue by Type (2023-2028) & (US$ Million)
Table 105. Middle East and Africa Medical Radioactive Isotopes Sales by Application (2017-2022) & (Curie)
Table 106. Middle East and Africa Medical Radioactive Isotopes Sales by Application (2023-2028) & (Curie)
Table 107. Middle East and Africa Medical Radioactive Isotopes Revenue by Application (2017-2022) & (US$ Million)
Table 108. Middle East and Africa Medical Radioactive Isotopes Revenue by Application (2023-2028) & (US$ Million)
Table 109. Middle East and Africa Medical Radioactive Isotopes Sales by Country (2017-2022) & (Curie)
Table 110. Middle East and Africa Medical Radioactive Isotopes Sales by Country (2023-2028) & (Curie)
Table 111. Middle East and Africa Medical Radioactive Isotopes Revenue by Country (2017-2022) & (US$ Million)
Table 112. Middle East and Africa Medical Radioactive Isotopes Revenue by Country (2023-2028) & (US$ Million)
Table 113. NRG Corporation Information
Table 114. NRG Description and Major Businesses
Table 115. NRG Medical Radioactive Isotopes Sales (Curie), Revenue (US$ Million), Price (US$/Curie) and Gross Margin (2017-2022)
Table 116. NRG Medical Radioactive Isotopes Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. NRG Recent Development
Table 118. IRE Corporation Information
Table 119. IRE Description and Major Businesses
Table 120. IRE Medical Radioactive Isotopes Sales (Curie), Revenue (US$ Million), Price (US$/Curie) and Gross Margin (2017-2022)
Table 121. IRE Medical Radioactive Isotopes Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. IRE Recent Development
Table 123. ANSTO Corporation Information
Table 124. ANSTO Description and Major Businesses
Table 125. ANSTO Medical Radioactive Isotopes Sales (Curie), Revenue (US$ Million), Price (US$/Curie) and Gross Margin (2017-2022)
Table 126. ANSTO Medical Radioactive Isotopes Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. ANSTO Recent Development
Table 128. NTP Radioisotopes Corporation Information
Table 129. NTP Radioisotopes Description and Major Businesses
Table 130. NTP Radioisotopes Medical Radioactive Isotopes Sales (Curie), Revenue (US$ Million), Price (US$/Curie) and Gross Margin (2017-2022)
Table 131. NTP Radioisotopes Medical Radioactive Isotopes Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. NTP Radioisotopes Recent Development
Table 133. China National Nuclear Corporation Corporation Information
Table 134. China National Nuclear Corporation Description and Major Businesses
Table 135. China National Nuclear Corporation Medical Radioactive Isotopes Sales (Curie), Revenue (US$ Million), Price (US$/Curie) and Gross Margin (2017-2022)
Table 136. China National Nuclear Corporation Medical Radioactive Isotopes Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. China National Nuclear Corporation Recent Development
Table 138. Rosatom Corporation Information
Table 139. Rosatom Description and Major Businesses
Table 140. Rosatom Medical Radioactive Isotopes Sales (Curie), Revenue (US$ Million), Price (US$/Curie) and Gross Margin (2017-2022)
Table 141. Rosatom Medical Radioactive Isotopes Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Rosatom Recent Development
Table 143. Nordion Corporation Information
Table 144. Nordion Description and Major Businesses
Table 145. Nordion Medical Radioactive Isotopes Sales (Curie), Revenue (US$ Million), Price (US$/Curie) and Gross Margin (2017-2022)
Table 146. Nordion Medical Radioactive Isotopes Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Nordion Recent Development
Table 148. Eckert & Ziegler Strahlen Corporation Information
Table 149. Eckert & Ziegler Strahlen Description and Major Businesses
Table 150. Eckert & Ziegler Strahlen Medical Radioactive Isotopes Sales (Curie), Revenue (US$ Million), Price (US$/Curie) and Gross Margin (2017-2022)
Table 151. Eckert & Ziegler Strahlen Medical Radioactive Isotopes Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Eckert & Ziegler Strahlen Recent Development
Table 153. Polatom Corporation Information
Table 154. Polatom Description and Major Businesses
Table 155. Polatom Medical Radioactive Isotopes Sales (Curie), Revenue (US$ Million), Price (US$/Curie) and Gross Margin (2017-2022)
Table 156. Polatom Medical Radioactive Isotopes Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Polatom Recent Development
Table 158. Key Raw Materials Lists
Table 159. Raw Materials Key Suppliers Lists
Table 160. Medical Radioactive Isotopes Distributors List
Table 161. Medical Radioactive Isotopes Customers List
Table 162. Medical Radioactive Isotopes Market Trends
Table 163. Medical Radioactive Isotopes Market Drivers
Table 164. Medical Radioactive Isotopes Market Challenges
Table 165. Medical Radioactive Isotopes Market Restraints
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Medical Radioactive Isotopes Product Picture
Figure 2. Global Medical Radioactive Isotopes Market Share by Type in 2021 & 2028
Figure 3. Tc-99m Product Picture
Figure 4. Cobalt-60 Product Picture
Figure 5. Iodine Radioisotopes Product Picture
Figure 6. Global Medical Radioactive Isotopes Market Share by Application in 2021 & 2028
Figure 7. Nuclear Therapy
Figure 8. Equipment Radioactive Source
Figure 9. Diagnosis
Figure 10. Others
Figure 11. Medical Radioactive Isotopes Report Years Considered
Figure 12. Global Medical Radioactive Isotopes Capacity, Production and Utilization (2017-2028) & (Curie)
Figure 13. Global Medical Radioactive Isotopes Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Medical Radioactive Isotopes Production Market Share by Region (2017-2022)
Figure 15. Global Medical Radioactive Isotopes Production Market Share by Region (2023-2028)
Figure 16. Medical Radioactive Isotopes Production Growth Rate in North America (2017-2028) & (Curie)
Figure 17. Medical Radioactive Isotopes Production Growth Rate in Europe (2017-2028) & (Curie)
Figure 18. Medical Radioactive Isotopes Production Growth Rate in China (2017-2028) & (Curie)
Figure 19. Medical Radioactive Isotopes Production Growth Rate in Japan (2017-2028) & (Curie)
Figure 20. Global Medical Radioactive Isotopes Sales 2017-2028 (Curie)
Figure 21. Global Medical Radioactive Isotopes Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 22. Global Medical Radioactive Isotopes Revenue 2017-2028 (US$ Million)
Figure 23. Global Medical Radioactive Isotopes Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 24. Global Medical Radioactive Isotopes Sales Market Share by Region (2017-2022)
Figure 25. Global Medical Radioactive Isotopes Sales Market Share by Region (2023-2028)
Figure 26. North America Medical Radioactive Isotopes Sales YoY (2017-2028) & (Curie)
Figure 27. North America Medical Radioactive Isotopes Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Europe Medical Radioactive Isotopes Sales YoY (2017-2028) & (Curie)
Figure 29. Europe Medical Radioactive Isotopes Revenue YoY (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Medical Radioactive Isotopes Sales YoY (2017-2028) & (Curie)
Figure 31. Asia-Pacific Medical Radioactive Isotopes Revenue YoY (2017-2028) & (US$ Million)
Figure 32. Latin America Medical Radioactive Isotopes Sales YoY (2017-2028) & (Curie)
Figure 33. Latin America Medical Radioactive Isotopes Revenue YoY (2017-2028) & (US$ Million)
Figure 34. Middle East & Africa Medical Radioactive Isotopes Sales YoY (2017-2028) & (Curie)
Figure 35. Middle East & Africa Medical Radioactive Isotopes Revenue YoY (2017-2028) & (US$ Million)
Figure 36. The Medical Radioactive Isotopes Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 37. The Top 5 and 10 Largest Manufacturers of Medical Radioactive Isotopes in the World: Market Share by Medical Radioactive Isotopes Revenue in 2021
Figure 38. Medical Radioactive Isotopes Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 39. Global Medical Radioactive Isotopes Sales Market Share by Type (2017-2028)
Figure 40. Global Medical Radioactive Isotopes Revenue Market Share by Type (2017-2028)
Figure 41. Global Medical Radioactive Isotopes Sales Market Share by Application (2017-2028)
Figure 42. Global Medical Radioactive Isotopes Revenue Market Share by Application (2017-2028)
Figure 43. North America Medical Radioactive Isotopes Sales Market Share by Type (2017-2028)
Figure 44. North America Medical Radioactive Isotopes Revenue Market Share by Type (2017-2028)
Figure 45. North America Medical Radioactive Isotopes Sales Market Share by Application (2017-2028)
Figure 46. North America Medical Radioactive Isotopes Revenue Market Share by Application (2017-2028)
Figure 47. North America Medical Radioactive Isotopes Sales Share by Country (2017-2028)
Figure 48. North America Medical Radioactive Isotopes Revenue Share by Country (2017-2028)
Figure 49. United States Medical Radioactive Isotopes Revenue (2017-2028) & (US$ Million)
Figure 50. Canada Medical Radioactive Isotopes Revenue (2017-2028) & (US$ Million)
Figure 51. Europe Medical Radioactive Isotopes Sales Market Share by Type (2017-2028)
Figure 52. Europe Medical Radioactive Isotopes Revenue Market Share by Type (2017-2028)
Figure 53. Europe Medical Radioactive Isotopes Sales Market Share by Application (2017-2028)
Figure 54. Europe Medical Radioactive Isotopes Revenue Market Share by Application (2017-2028)
Figure 55. Europe Medical Radioactive Isotopes Sales Share by Country (2017-2028)
Figure 56. Europe Medical Radioactive Isotopes Revenue Share by Country (2017-2028)
Figure 57. Germany Medical Radioactive Isotopes Revenue (2017-2028) & (US$ Million)
Figure 58. France Medical Radioactive Isotopes Revenue (2017-2028) & (US$ Million)
Figure 59. U.K. Medical Radioactive Isotopes Revenue (2017-2028) & (US$ Million)
Figure 60. Italy Medical Radioactive Isotopes Revenue (2017-2028) & (US$ Million)
Figure 61. Russia Medical Radioactive Isotopes Revenue (2017-2028) & (US$ Million)
Figure 62. Asia Pacific Medical Radioactive Isotopes Sales Market Share by Type (2017-2028)
Figure 63. Asia Pacific Medical Radioactive Isotopes Revenue Market Share by Type (2017-2028)
Figure 64. Asia Pacific Medical Radioactive Isotopes Sales Market Share by Application (2017-2028)
Figure 65. Asia Pacific Medical Radioactive Isotopes Revenue Market Share by Application (2017-2028)
Figure 66. Asia Pacific Medical Radioactive Isotopes Sales Share by Region (2017-2028)
Figure 67. Asia Pacific Medical Radioactive Isotopes Revenue Share by Region (2017-2028)
Figure 68. China Medical Radioactive Isotopes Revenue (2017-2028) & (US$ Million)
Figure 69. Japan Medical Radioactive Isotopes Revenue (2017-2028) & (US$ Million)
Figure 70. South Korea Medical Radioactive Isotopes Revenue (2017-2028) & (US$ Million)
Figure 71. India Medical Radioactive Isotopes Revenue (2017-2028) & (US$ Million)
Figure 72. Australia Medical Radioactive Isotopes Revenue (2017-2028) & (US$ Million)
Figure 73. China Taiwan Medical Radioactive Isotopes Revenue (2017-2028) & (US$ Million)
Figure 74. Indonesia Medical Radioactive Isotopes Revenue (2017-2028) & (US$ Million)
Figure 75. Thailand Medical Radioactive Isotopes Revenue (2017-2028) & (US$ Million)
Figure 76. Malaysia Medical Radioactive Isotopes Revenue (2017-2028) & (US$ Million)
Figure 77. Latin America Medical Radioactive Isotopes Sales Market Share by Type (2017-2028)
Figure 78. Latin America Medical Radioactive Isotopes Revenue Market Share by Type (2017-2028)
Figure 79. Latin America Medical Radioactive Isotopes Sales Market Share by Application (2017-2028)
Figure 80. Latin America Medical Radioactive Isotopes Revenue Market Share by Application (2017-2028)
Figure 81. Latin America Medical Radioactive Isotopes Sales Share by Country (2017-2028)
Figure 82. Latin America Medical Radioactive Isotopes Revenue Share by Country (2017-2028)
Figure 83. Mexico Medical Radioactive Isotopes Revenue (2017-2028) & (US$ Million)
Figure 84. Brazil Medical Radioactive Isotopes Revenue (2017-2028) & (US$ Million)
Figure 85. Argentina Medical Radioactive Isotopes Revenue (2017-2028) & (US$ Million)
Figure 86. Colombia Medical Radioactive Isotopes Revenue (2017-2028) & (US$ Million)
Figure 87. Middle East and Africa Medical Radioactive Isotopes Sales Market Share by Type (2017-2028)
Figure 88. Middle East and Africa Medical Radioactive Isotopes Revenue Market Share by Type (2017-2028)
Figure 89. Middle East and Africa Medical Radioactive Isotopes Sales Market Share by Application (2017-2028)
Figure 90. Middle East and Africa Medical Radioactive Isotopes Revenue Market Share by Application (2017-2028)
Figure 91. Middle East and Africa Medical Radioactive Isotopes Sales Share by Country (2017-2028)
Figure 92. Middle East and Africa Medical Radioactive Isotopes Revenue Share by Country (2017-2028)
Figure 93. Turkey Medical Radioactive Isotopes Revenue (2017-2028) & (US$ Million)
Figure 94. Saudi Arabia Medical Radioactive Isotopes Revenue (2017-2028) & (US$ Million)
Figure 95. UAE Medical Radioactive Isotopes Revenue (2017-2028) & (US$ Million)
Figure 96. Medical Radioactive Isotopes Value Chain
Figure 97. Medical Radioactive Isotopes Production Process
Figure 98. Channels of Distribution
Figure 99. Distributors Profiles
Figure 100. Bottom-up and Top-down Approaches for This Report
Figure 101. Data Triangulation
Figure 102. Key Executives Interviewed


★調査レポート[医療用放射性同位体の世界市場インサイト・予測（～2028年）] (コード：QY22JLX01556)販売に関する免責事項を必ずご確認ください。
★調査レポート[医療用放射性同位体の世界市場インサイト・予測（～2028年）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 医療用放射線源の世界市場インサイト・予測（～2028年）
  • 放射性ヨウ素吸着剤の世界市場インサイト・予測（～2028年）
  • アメリシウム241放射性物質の世界市場インサイト・予測（～2028年）
  • 産業用放射線源の世界市場インサイト・予測（～2028年）
  • 世界のバナジウム放射性同位体市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆